Company Spotlight

Adare Pharmaceuticals

1200 Lenox Drive
Princeton Pike Corporate Center, Suite 100
Lawrence Township, NJ 08648
United States
View Profile

Aphena Pharma Solutions, Inc.

1920 Fisk Road
Cookeville, TN 38506
United States
View Profile

Cytovance Biologics

800 Research Pkwy., Suite 200
Oklahoma City, OK 73104
United States
View Profile


Contract Service Directory


AMRI





Company Headquarters

26 Corporate Circle
Albany, NY 12203
United States

Company Description

AMRI, a global contract research and manufacturing organization, partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life. With locations in North America, Europe and Asia, AMRI’s team combines scientific expertise and market-leading technology to provide a complete suite of solutions in Discovery, Development, Analytical and Solid State Services, API Manufacturing and Drug Product. For more information about AMRI, visit https://www.amriglob al.com.

Contract Service Directory

    Content From AMRI

    Related Content

    • Breaking News | Formulation Development | Industry News
      Catalent, Bridge Therapeutics Execute Exclusive License Agreement

      Catalent, Bridge Therapeutics Execute Exclusive License Agreement

      To utilize Catalent’s Zydis orally disintegrating tablet (ODT) technology for opioid addiction therapeutic product
      12.10.19

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      WuXi Biologics Makes Second Major Investment in Ireland

      WuXi Biologics Makes Second Major Investment in Ireland

      To build a $240 million vaccine manufacturing facility on its Dundalk site.
      12.09.19

    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
      WuXi Vaccines to Build a New Vaccine Mfg. Facility in Ireland

      WuXi Vaccines to Build a New Vaccine Mfg. Facility in Ireland

      Dedicated facility will supply a vaccine product of a large global pharma for the global market
      11.25.19


    • Aseptic Processing | Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | Fill/Finish | Parenterals
      Contract Pharma’s 20th Anniversary Series: Vetter

      Contract Pharma’s 20th Anniversary Series: Vetter

      Oskar Gold of Vetter discusses vital changes in the industry and the science and technology needed to support advanced therapeutics
      Kristin Brooks, Contract Pharma 11.13.19

    • German Pharma Benefiting From a Brexit Boost?

      German Pharma Benefiting From a Brexit Boost?

      Germany consolidates itself as world leader in pharma according to the CPhI Pharma Index.
      10.29.19

    • AAPS Event Info

      AAPS Event Info

      Conference: November 3-6, 2019 | San Antonio, Texas Henry B. Gonzalez Convention Center 900 E Market Street,  San Antonio, TX 78205 Registrion Pricing Member Rates   Regular $1,175…
      10.28.19


    • Bio News | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
      Lonza, Citryll Enter Manufacturing Partnership

      Lonza, Citryll Enter Manufacturing Partnership

      Lonza to supply final drug product in finished format for Citryll’s clinical studies
      09.10.19

    • Clinical Trials | CRO News | Drug Development
      AES Acquires Bioclinica

      AES Acquires Bioclinica's Clinical Research Site Biz

      Expands global footprint and position in patient access and site conduct
      09.06.19

    • Analytical Services | cGMP Manufacture | Clinical Trial Materials | Drug Development | Industry News
      Permira Funds to Acquire Cambrex in $2.4B Transaction

      Permira Funds to Acquire Cambrex in $2.4B Transaction

      To back Cambrex in its next phase of growth
      08.07.19


    • Bio News | Breaking News | Collaborations & Alliances | Industry News | Injectables | R&D
      Biological E, GVK BIO Enter R&D Partnership

      Biological E, GVK BIO Enter R&D Partnership

      GVK will develop injectable products for BE
      08.02.19

    • Breaking News | Industry News
      Eurofins Amatsigroup Rebrands to Eurofins CDMO

      Eurofins Amatsigroup Rebrands to Eurofins CDMO

      Provides integrated, end-to-end solutions for pre-clinical and clinical outsourcing services
      07.31.19

    • Promotions & Moves
      MHI Appoints National Accounts Manager

      MHI Appoints National Accounts Manager

      McCracken to help lead sales for emerging player in North American blister machinery market
      07.18.19


    • Ergomed Proposes Appointment of Former Chiltern CEO

      Ergomed Proposes Appointment of Former Chiltern CEO

      Dr. Jim Esinhart to be appointed as a Non-Executive Director of the Company
      07.10.19